Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00473486 | Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib(PECASO) | terminated | Phase 1 / Phase 2 | 12 | University Hospital MuensterOTHER | 1 | Jan 27, 2010 | clinicaltrials |
| NCT00378573 | Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | terminated | Phase 2 | 17 | SanofiINDUSTRY | 1 |
| Jan 26, 2010 |
| clinicaltrials |
| NCT00813332 | Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC) | unknown | Phase 4 | 300 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Jan 25, 2010 | clinicaltrials |
| NCT00264134 | Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 40 | Kentuckiana Cancer InstituteOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT01051362 | Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 48 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jan 18, 2010 | clinicaltrials |
| NCT00516100 | Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC | unknown | Phase 1 / Phase 2 | 62 | Aptium Oncology Research NetworkNETWORK | 1 | Jan 15, 2010 | clinicaltrials |
| NCT01048970 | Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer | unknown | Phase 2 / Phase 3 | 120 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 14, 2010 | clinicaltrials |
| NCT00002901 | Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT01048645 | Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 107 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00277082 | Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung | completed | — | 24 | University of New MexicoOTHER | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00322751 | Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer | completed | Phase 1 | 10 | University of New MexicoOTHER | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00997724 | Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer(VATS) | unknown | Phase 2 | 100 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jan 5, 2010 | clinicaltrials |
| NCT01041833 | Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker | unknown | Phase 3 | 230 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 1, 2010 | clinicaltrials |
| NCT01037998 | UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer | completed | Phase 2 | 115 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00615758 | Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV | completed | Phase 2 | 50 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00684099 | Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 70 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00191191 | To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 226 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 9, 2009 | clinicaltrials |
| NCT01028729 | A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC)(NSCLC) | unknown | Phase 4 | 120 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00271271 | Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients(GON) | completed | Phase 2 | 40 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00424853 | ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC) | completed | Phase 2 | 88 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00425191 | Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer. | completed | Phase 2 | 165 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00598065 | The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules | completed | N/A | 26 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 3, 2009 | clinicaltrials |
| NCT00752076 | Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment(EGFR) | unknown | N/A | 100 | National Taiwan University HospitalOTHER | 1 | Dec 1, 2009 | clinicaltrials |
| NCT01019798 | Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer | unknown | Phase 2 | 16 | Taipei Medical University HospitalOTHER | 1 | Nov 25, 2009 | clinicaltrials |
| NCT00099541 | Non-small Cell Lung Cancer Registry | completed | Phase 4 | 300 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00494026 | Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC) | terminated | Phase 2 | 4 | Eli Lilly and CompanyINDUSTRY | 4 | Nov 20, 2009 | clinicaltrials |
| NCT00608452 | Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers | completed | — | 121 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 13, 2009 | clinicaltrials |
| NCT01004601 | Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer | completed | N/A | 179 | Chang Gung Memorial HospitalOTHER | 1 | Oct 30, 2009 | clinicaltrials |
| NCT00363415 | Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 908 | Eli Lilly and CompanyINDUSTRY | 26 | Oct 28, 2009 | clinicaltrials |
| NCT00447421 | A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy | terminated | Phase 1 / Phase 2 | 9 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 28, 2009 | clinicaltrials |
| NCT01003522 | Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer(RESTORE-AIR) | unknown | Phase 3 | 60 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 28, 2009 | clinicaltrials |
| NCT01000428 | The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer | unknown | — | 34 | Asan Medical CenterOTHER | 1 | Oct 27, 2009 | clinicaltrials |
| NCT00370292 | Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 19 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 20, 2009 | clinicaltrials |
| NCT00212043 | Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma | completed | Phase 2 | 74 | National University Hospital, SingaporeOTHER | 0 | Oct 8, 2009 | clinicaltrials |
| NCT00982605 | EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN) | unknown | — | 50 | Heidelberg UniversityOTHER | 1 | Oct 6, 2009 | clinicaltrials |
| NCT00319969 | Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. | completed | Phase 2 | 76 | Celgene CorporationINDUSTRY | 1 | Sep 30, 2009 | clinicaltrials |
| NCT00313768 | Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC | terminated | Phase 2 | 23 | PfizerINDUSTRY | 1 | Sep 28, 2009 | clinicaltrials |
| NCT00321308 | Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 36 | PfizerINDUSTRY | 3 | Sep 28, 2009 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00273507 | Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 | terminated | Phase 3 | 270 | Rigshospitalet, DenmarkOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00568841 | Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)(ERLOPET) | unknown | Phase 2 | 40 | Lung Cancer Group CologneOTHER | 1 | Sep 17, 2009 | clinicaltrials |
| NCT00461110 | A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC) | terminated | Phase 1 | 35 | Bristol-Myers SquibbINDUSTRY | 1 | Sep 4, 2009 | clinicaltrials |
| NCT00964132 | Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 48 | NuRx Pharmaceuticals, Inc.INDUSTRY | 1 | Sep 3, 2009 | clinicaltrials |
| NCT00004924 | Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 28 | Yale UniversityOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00801385 | Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy | unknown | Phase 2 | 47 | Yonsei UniversityOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00063219 | Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy | completed | Phase 2 | 48 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Aug 21, 2009 | clinicaltrials |
| NCT00067548 | Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 44 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00434226 | A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L) | terminated | Phase 2 | 56 | Genentech, Inc.INDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00963716 | Hot and Cold Biopsy Forceps in the Diagnosis of Endobronchial Lesions | completed | N/A | 168 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Aug 21, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Jan 27, 2010source: clinicaltrials